Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin with nitric oxide and/or prostacyclin during paediatric cardiopulmonary bypass
ACTRN12606000057583Phase 3Not yet recruiting
- Sponsor
- The Royal Children's Hospital
- Start
- Apr 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of heparin, nitric oxide and Caripul in Cardiovascular Malformation (CVM) (4 arms), sponsored by The Royal Children's Hospital. Primary endpoints: Reduction in platelet and coagulation cascade activation and Preservation of platelet function. Planned start Apr 2006; status: not yet recruiting.
02
Drugs
heparinnitric oxideCaripul
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ACTRN12606000057583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000057583.